Join to View Full Profile
9200 W Wisconsin AveNeoplastic DiseasesMilwaukee, WI 53226
Phone+1 414-805-6800
Fax+1 414-805-6805
Dr. Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stuart Wong is an oncologist based in Milwaukee, WI, with a focus on head and neck oncology. He graduated from the Medical College of Wisconsin in 1990 and completed his residency and fellowship at the same institution's affiliated hospitals. Dr. Wong has contributed to numerous publications on head and neck cancer, including articles in journals such as Head & Neck, The Lancet Oncology, and JAMA Oncology. He has led multiple clinical trials centered on head and neck carcinoma and radiation-induced pain management. His professional accolades include being named a Regional Top Doctor by Castle Connolly and receiving the CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1994 - 1998- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1990 - 1993
- Medical College of WisconsinClass of 1990
Certifications & Licensure
WI State Medical License 1992 - 2025
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Apr 01
- Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Nov 01
- Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Publications & Presentations
PubMed
- Tumoral Skin Invasion Is an Independent Predictor of Rapid Recurrence in Head and Neck Cancer.Abdullah A Memon, Mohamed Khalil, Oscar Villarreal Espinosa, Imaad Said, Eric Yang
Head & Neck. 2026-02-01 - Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy Approaches.Imaad Said, Musaddiq J Awan, Stuart J Wong, Abdullah A Memon, Tyce Kearl
International Journal of Radiation Oncology, Biology, Physics. 2026-01-01 - Patterns of response in head and neck cancer subregions using daily Quantitative MRI from MR-guided radiation therapy.Ryan Bonate, Musaddiq Awan, Heather Himburg, Stuart Wong, Monica Shukla
Clinical and Translational Radiation Oncology. 2026-01-01
Journal Articles
- E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced MelanomaArun Nagarajan, Mark R Albertini, Stuart Wong, Noel Laudi, Robert M Conry, Clinical Cancer Research
Press Mentions
Plenary Highlights Across Tumor Types Reflect Advances in Research, Improvements in Care, and Changes in PracticeJuly 25th, 2025- Romiplostim Effective in Managing CIT in GI CancersJune 3rd, 2025
- “Phenomenal” Results with Perioperative Immunotherapy in NSCLCJune 3rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
